Mainstream

Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations

Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations

Post ContentcaprRead More

You might also be interested in reading Avalanche Looks To Capitalize On GameFi Segment – Will This Give AVAX Some Boost?.

May 14, 2025
In Mainstream